Menu

Star on GitHub · 3.2k

CVE-2024-52010

Zoraxy is a general purpose HTTP reverse proxy and forwarding tool.

Published Nov 12, 2024CWE-78EPSS 1.50%

Overview

CVE-2024-52010 is a known-severity vulnerability. It was published on November 12, 2024.

Technical description

Zoraxy is a general purpose HTTP reverse proxy and forwarding tool. A command injection vulnerability in the Web SSH feature allows an authenticated attacker to execute arbitrary commands as root on the host. Zoraxy has a Web SSH terminal feature that allows authenticated users to connect to SSH servers from their browsers. In HandleCreateProxySession the request to create an SSH session is handled. An attacker can exploit the username variable to escape from the bash command and inject arbitrary commands into sshCommand. This is possible, because, unlike hostname and port, the username is not validated or sanitized.

Remediation

Check the references section for vendor advisories, patches, and mitigation guidance. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

Frequently asked questions

What is CVE-2024-52010?

CVE-2024-52010 is a known-severity vulnerability. It was published on November 12, 2024.

How severe is CVE-2024-52010?

CVSS score information is not yet available for this vulnerability. Check back as the CVE record is updated by NVD analysts.

How do I fix or remediate CVE-2024-52010?

Check the references section for vendor advisories, patches, and mitigation guidance. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

How can CyberStrike help with CVE-2024-52010?

CyberStrike is an open-source, AI-augmented pentesting engine. Rather than flag a version number, it tests whether an issue like CVE-2024-52010 is actually reachable in your own applications and APIs, then verifies each finding before reporting it. That tells you if the weakness is a real, exploitable risk in your environment or a false positive you can safely deprioritize.